OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,451,000 | -1.0% | 499,193 | 0.0% | 0.02% | +9.1% |
Q3 2016 | $2,476,000 | -2.6% | 499,193 | 0.0% | 0.02% | -18.5% |
Q2 2016 | $2,541,000 | -10.8% | 499,193 | 0.0% | 0.03% | -10.0% |
Q1 2016 | $2,850,000 | -45.0% | 499,193 | 0.0% | 0.03% | -30.2% |
Q4 2015 | $5,182,000 | -43.8% | 499,193 | 0.0% | 0.04% | -49.4% |
Q3 2015 | $9,220,000 | -5.1% | 499,193 | 0.0% | 0.08% | 0.0% |
Q2 2015 | $9,714,000 | +10.7% | 499,193 | 0.0% | 0.08% | +16.4% |
Q1 2015 | $8,776,000 | +7.5% | 499,193 | -2.2% | 0.07% | -12.0% |
Q4 2014 | $8,165,000 | +27.0% | 510,606 | 0.0% | 0.08% | +2.5% |
Q3 2014 | $6,429,000 | -19.4% | 510,606 | 0.0% | 0.08% | -17.3% |
Q2 2014 | $7,976,000 | +68.0% | 510,606 | +41.2% | 0.10% | +63.3% |
Q1 2014 | $4,747,000 | -21.3% | 361,530 | -3.7% | 0.06% | -29.4% |
Q4 2013 | $6,035,000 | -3.4% | 375,282 | 0.0% | 0.08% | -4.5% |
Q3 2013 | $6,245,000 | – | 375,282 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,240,709 | $23,259,000 | 3.12% |
PRINCETON CAPITAL MANAGEMENT INC | 34,825 | $361,000 | 0.25% |
Freedom Investment Management, Inc. | 118,284 | $1,228,000 | 0.09% |
Spark Investment Management LLC | 62,800 | $651,000 | 0.08% |
GSA CAPITAL PARTNERS LLP | 98,901 | $1,027,000 | 0.05% |
Baker Brothers Advisors | 499,193 | $5,182,000 | 0.04% |
KILLEN GROUP INC | 31,000 | $322,000 | 0.03% |
GROUP ONE TRADING, L.P. | 127,263 | $1,321,000 | 0.02% |
A.R.T. Advisors, LLC | 27,049 | $280,000 | 0.01% |
QS Investors, LLC | 132,027 | $1,370,000 | 0.01% |